Evidence map›Paper›PMID 42621724›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Selective Modulation of OTUB1 Noncanonical Function via a bioPhosTAC Strategy.

Seung Un Seo, Seon Min Woo, Minhyeong Choi, Soeun Rhee, Simmyung Yook, Donghyuk Shin, Kwang-Su Park, Taeg Kyu Kwon

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Seung Un SeoDepartment of Immunology, School of Medicine, Keimyung University, Daegu, South Korea.
Seon Min WooDepartment of Immunology, School of Medicine, Keimyung University, Daegu, South Korea.
Minhyeong ChoiDepartment of Systems Biology, College of Life Science and Biotechnology, Yonsei University, Seoul, South Korea.ORCID https://orcid.org/0009-0001-1122-5622
Soeun RheeDepartment of Systems Biology, College of Life Science and Biotechnology, Yonsei University, Seoul, South Korea.ORCID https://orcid.org/0009-0001-9817-9269
Simmyung YookSchool of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi, South Korea.ORCID https://orcid.org/0000-0003-2129-1890
Donghyuk ShinDepartment of Systems Biology, College of Life Science and Biotechnology, Yonsei University, Seoul, South Korea.ORCID https://orcid.org/0000-0002-8272-6133
Kwang-Su ParkCollege of Pharmacy, Keimyung University, Daegu, South Korea.ORCID https://orcid.org/0000-0002-1910-3937
Taeg Kyu KwonDepartment of Immunology, School of Medicine, Keimyung University, Daegu, South Korea.ORCID https://orcid.org/0000-0003-1204-2059

Funding

Bio&Medical Technology Development Program of the National Research Foundation RS-2022-NR067425National Institute of Health 2025-ER2011-00 2025-ER2011-01National Research Foundation of Korea 2021R1C1C100396112National Research Foundation of Korea RS-2024-00348057National Research Foundation of Korea RS-2024-00406114National Research Foundation of Korea RS-2025-18362970
6 · The paper itself

Abstract

OTUB1 is a canonical deubiquitinating enzyme that hydrolyzes K48-linked polyubiquitin chains as well as a regulator of several noncanonical pathways controlled by site-specific post-translational modifications. Phosphorylation at tyrosine 26 (Y26) of OTUB1 recently emerged as a key regulatory switch that stabilizes Raptor (central component of mTORC1), thereby enhancing mTORC1 activity and influencing cell growth and metabolism. Selective modulation of Y26 phosphorylation offers an opportunity to elucidate the noncanonical roles of OTUB1 without perturbing its catalytic activity. However, genetic or kinase inhibition strategies lack the specificity to separate these functions. Here, a tyrosine-specific targeted protein dephosphorylation strategy was developed by recruiting the protein tyrosine phosphatase, SHP2, to OTUB1 via a peptide-based bifunctional molecule, termed bioPhosTAC. This bioPhosTAC comprises an OTUB1-binding peptide linked to an SHP2-binding peptide through a short linker, enabling proximity-induced Y26 dephosphorylation. The bioPhosTAC selectively reduced OTUB1 Y26 phosphorylation resulted in Raptor-related mitochondrial fusion and Bim upregulation. This study represents the first demonstration of a peptide-based SHP2-mediated bioPhosTAC system for selective tyrosine dephosphorylation through induced proximity. These findings provide a new chemical biology tool for dissecting the noncanonical roles of OTUB1 and broaden the scope of targeted protein dephosphorylation strategies to tyrosine phosphorylation, potentially allowing precise modulation of phospho-dependent signaling.

Indexed as

bioPhosTACOTUB1phosphorylationtyrosine phosphatase

Identifiers

PMID42621724
PMCPMC13491355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.